Advani, R., Forero-Torres, A., Furman, R. R., Rosenblatt, J. D., Younes, A., Ren, H., . . . Drachman, J. G. (2009). Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma. Journal of clinical oncology, 27(26), 4371. https://doi.org/10.1200/JCO.2008.21.3017
Chicago-Zitierstil (17. Ausg.)Advani, Ranjana, Andres Forero-Torres, Richard R. Furman, Joseph D. Rosenblatt, Anas Younes, Hong Ren, Kate Harrop, Nancy Whiting, und Jonathan G. Drachman. "Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma." Journal of Clinical Oncology 27, no. 26 (2009): 4371. https://doi.org/10.1200/JCO.2008.21.3017.
MLA-Zitierstil (9. Ausg.)Advani, Ranjana, et al. "Phase I Study of the Humanized Anti-CD40 Monoclonal Antibody Dacetuzumab in Refractory or Recurrent Non-Hodgkin's Lymphoma." Journal of Clinical Oncology, vol. 27, no. 26, 2009, p. 4371, https://doi.org/10.1200/JCO.2008.21.3017.